Skip to main content
Top
Published in: Supportive Care in Cancer 4/2012

01-04-2012 | Original Article

Acupuncture improves health-related quality-of-life (HRQoL) and sleep in women with breast cancer and hot flushes

Authors: Jessica Frisk, Ann-Christine Källström, Najme Wall, Mats Fredrikson, Mats Hammar

Published in: Supportive Care in Cancer | Issue 4/2012

Login to get access

Abstract

Purpose

Evaluate effects of electro-acupuncture (EA) and hormone therapy (HT) on health-related quality-of-life (HRQoL) and sleep in breast cancer survivors with vasomotor symptoms.

Methods

Forty-five women, randomized to EA (n = 27) for 12 weeks or HT (n = 18) for 24 months, were followed for up to 2 years. Distress caused by, and numbers of, hot flushes, hours slept and times woken up/night, Psychological and General Well-being Index (PGWB) and Women’s Health Questionnaire (WHQ) were registered before and during treatment and at 6, 9, 12, 18 and 24 months after start of treatment.

Results

After 12 weeks of EA (n = 19), WHQ improved from 0.32 (IQR 0.23–0.53) at baseline to 0.24 (IQR 0.12–0.39; p < 0.001) and PGWB from 78 (IQR 53–89) to 79 (IQR 68–93; p = 0.002). All sleep parameters improved and Hot Flush Score (HFS) decreased by 80%. At 12 months, WHQ, PGWB and all sleep parameters remained significantly improved (n = 14) and HFS decreased by 65%. After 12 weeks of HT (n = 18), WHQ improved from 0.29 (IQR 0.15–0.44) at baseline to 0.15 (IQR 0.05–0.22; p = 0.001), PGWB from 75 (IQR 59–88) to 90 (62–97; p = 0.102) and three of five sleep parameters improved.

Conclusion

Both EA and HT increased HRQoL and sleep, probably through decreasing numbers of and distress by hot flushes. Although flushes decreased less in the EA group than in the HT group, HRQoL improved at least to the same extent maybe due to other effects of EA, not induced by HT, e.g. on anxiety, vitality and sleep, supported by subscale analyses. EA should be further evaluated as treatment for women with breast cancer and climacteric complaints, since HT no longer can be recommended for these women.
Appendix
Available only for authorised users
Literature
1.
go back to reference Montazeri A (2009) Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 7:102PubMedCrossRef Montazeri A (2009) Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 7:102PubMedCrossRef
2.
go back to reference Montazeri A (2008) Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 27:32PubMedCrossRef Montazeri A (2008) Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 27:32PubMedCrossRef
3.
go back to reference Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743–753PubMed Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743–753PubMed
4.
go back to reference Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M (2010) I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res 19:1419–1427PubMedCrossRef Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M (2010) I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res 19:1419–1427PubMedCrossRef
5.
go back to reference Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH (1998) Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16:1689–1696PubMed Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH (1998) Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16:1689–1696PubMed
6.
go back to reference Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T, Mikami I, Hosaka T, Uchitomi Y (2000) Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer 8:215–222PubMedCrossRef Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T, Mikami I, Hosaka T, Uchitomi Y (2000) Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer 8:215–222PubMedCrossRef
7.
go back to reference Gupta P, Sturdee D, Pallin S, Majumder K, Fear R, Marshall T, Paterson I (2006) Menopausal symptoms in women treated for breast cancer; the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 9:49–58PubMedCrossRef Gupta P, Sturdee D, Pallin S, Majumder K, Fear R, Marshall T, Paterson I (2006) Menopausal symptoms in women treated for breast cancer; the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 9:49–58PubMedCrossRef
8.
go back to reference Savard J, Davidson JR, Ivers H, Quesnel C, Rioux D, Dupere V, Lasnier M, Simard S, Morin CM (2004) The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage 27:513–522PubMedCrossRef Savard J, Davidson JR, Ivers H, Quesnel C, Rioux D, Dupere V, Lasnier M, Simard S, Morin CM (2004) The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage 27:513–522PubMedCrossRef
9.
go back to reference Rand KL, Otte JL, Flockhart D, Hayes D, Storniolo AM, Stearns V, Henry NL, Nguyen A, Lemler S, Hayden J, Jeter S, Carpenter JS (2011) Modeling hot flushes and quality of life in breast cancer survivors. Climacteric 14:171–180. doi:10.3109/13697131003717070 PubMedCrossRef Rand KL, Otte JL, Flockhart D, Hayes D, Storniolo AM, Stearns V, Henry NL, Nguyen A, Lemler S, Hayden J, Jeter S, Carpenter JS (2011) Modeling hot flushes and quality of life in breast cancer survivors. Climacteric 14:171–180. doi:10.​3109/​1369713100371707​0 PubMedCrossRef
10.
go back to reference Kronenberg F (1990) Hot flashes: epidemiology and physiology. Ann NY Acad Sci 592:52–86, discussion 123–133PubMedCrossRef Kronenberg F (1990) Hot flashes: epidemiology and physiology. Ann NY Acad Sci 592:52–86, discussion 123–133PubMedCrossRef
11.
go back to reference Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA (2002) Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 23:501–509PubMedCrossRef Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA (2002) Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 23:501–509PubMedCrossRef
12.
go back to reference Cella D, Fallowfield L (2008) Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat 107:167–180PubMedCrossRef Cella D, Fallowfield L (2008) Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat 107:167–180PubMedCrossRef
13.
go back to reference Fahlen M, Wallberg B, von Schoultz E, Carlstrom K, Svensson G, Wilking N, Brandberg Y (2010) Health-related quality of life during hormone therapy after breast cancer: a randomized trial. Climacteric Epub ahead. doi:10.3109/13697131003660593 Fahlen M, Wallberg B, von Schoultz E, Carlstrom K, Svensson G, Wilking N, Brandberg Y (2010) Health-related quality of life during hormone therapy after breast cancer: a randomized trial. Climacteric Epub ahead. doi:10.​3109/​1369713100366059​3
14.
go back to reference Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the women's health initiative randomized trial. JAMA 289:3243–3253PubMedCrossRef Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the women's health initiative randomized trial. JAMA 289:3243–3253PubMedCrossRef
15.
go back to reference Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419–427PubMedCrossRef Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419–427PubMedCrossRef
16.
go back to reference Holmberg L, Iversen OE, Rudenstam CM, Hammar M, Kumpulainen E, Jaskiewicz J, Jassem J, Dobaczewska D, Fjosne HE, Peralta O, Arriagada R, Holmqvist M, Maenpaa J (2008) Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst 100:475–482PubMedCrossRef Holmberg L, Iversen OE, Rudenstam CM, Hammar M, Kumpulainen E, Jaskiewicz J, Jassem J, Dobaczewska D, Fjosne HE, Peralta O, Arriagada R, Holmqvist M, Maenpaa J (2008) Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst 100:475–482PubMedCrossRef
17.
go back to reference Filshie J, Bolton T, Browne D, Ashley S (2005) Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients–audit and treatment algorithm. Acupunct Med 23:171–180PubMedCrossRef Filshie J, Bolton T, Browne D, Ashley S (2005) Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients–audit and treatment algorithm. Acupunct Med 23:171–180PubMedCrossRef
18.
go back to reference Walker EM, Rodriguez AI, Kohn B, Ball RM, Pegg J, Pocock JR, Nunez R, Peterson E, Jakary S, Levine RA (2010) Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol 28:634–640PubMedCrossRef Walker EM, Rodriguez AI, Kohn B, Ball RM, Pegg J, Pocock JR, Nunez R, Peterson E, Jakary S, Levine RA (2010) Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol 28:634–640PubMedCrossRef
19.
go back to reference MacPherson H, Altman DG, Hammerschlag R, Li Y, Wu T, White A, Moher D (2010) Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med 28:83–93PubMedCrossRef MacPherson H, Altman DG, Hammerschlag R, Li Y, Wu T, White A, Moher D (2010) Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med 28:83–93PubMedCrossRef
20.
go back to reference Wyon YLR, Lundeberg T, Hammar M (1995) Effects of acupuncture on climacteric vasomotor symptoms, quality of life, and urinary excretion of neuropeptides among postmenopausal women. Menopause 2:3–12CrossRef Wyon YLR, Lundeberg T, Hammar M (1995) Effects of acupuncture on climacteric vasomotor symptoms, quality of life, and urinary excretion of neuropeptides among postmenopausal women. Menopause 2:3–12CrossRef
21.
go back to reference Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H (2001) Methodologic lessons learned from hot flash studies. J Clin Oncol 19:4280–4290PubMed Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H (2001) Methodologic lessons learned from hot flash studies. J Clin Oncol 19:4280–4290PubMed
22.
go back to reference Wiklund I, Karlberg J, Lindgren R, Sandin K, Mattsson LA (1993) A Swedish version of the Women's Health Questionnaire. A measure of postmenopausal complaints. Acta Obstet Gynecol Scand 72:648–655PubMedCrossRef Wiklund I, Karlberg J, Lindgren R, Sandin K, Mattsson LA (1993) A Swedish version of the Women's Health Questionnaire. A measure of postmenopausal complaints. Acta Obstet Gynecol Scand 72:648–655PubMedCrossRef
23.
go back to reference Hunter M (1992) The Women´s Health Questionnaire: a measure of mid-aged women´s perceptions of their emotional and physical health. Psychol Health 7:45–54CrossRef Hunter M (1992) The Women´s Health Questionnaire: a measure of mid-aged women´s perceptions of their emotional and physical health. Psychol Health 7:45–54CrossRef
24.
go back to reference Dupuy HJ (1984) The Psychological General Well-Being (PGWB) index. Le Jacq Publishing Inc, New York Dupuy HJ (1984) The Psychological General Well-Being (PGWB) index. Le Jacq Publishing Inc, New York
25.
go back to reference Wiklund I, Karlberg J (1991) Evaluation of quality of life in clinical trials. Selecting quality-of-life measures. Control Clin Trials 12:204S–216SPubMedCrossRef Wiklund I, Karlberg J (1991) Evaluation of quality of life in clinical trials. Selecting quality-of-life measures. Control Clin Trials 12:204S–216SPubMedCrossRef
26.
go back to reference Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH (1986) The effects of antihypertensive therapy on the quality of life. N Engl J Med 314:1657–1664PubMedCrossRef Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH (1986) The effects of antihypertensive therapy on the quality of life. N Engl J Med 314:1657–1664PubMedCrossRef
27.
go back to reference Frisk J, Carlhall S, Kallstrom AC, Lindh-Astrand L, Malmstrom A, Hammar M (2008) Long-term follow-up of acupuncture and hormone therapy on hot flushes in women with breast cancer: a prospective, randomized, controlled multicenter trial. Climacteric 11:166–174PubMedCrossRef Frisk J, Carlhall S, Kallstrom AC, Lindh-Astrand L, Malmstrom A, Hammar M (2008) Long-term follow-up of acupuncture and hormone therapy on hot flushes in women with breast cancer: a prospective, randomized, controlled multicenter trial. Climacteric 11:166–174PubMedCrossRef
28.
go back to reference Lee HJ, Lee JH, Lee EO, Lee HJ, Kim KH, Lee KS, Lee CH, Nam DW, Kim SH, Lee HJ, Ahn KS (2009) Substance P and beta endorphin mediate electroacupuncture induced analgesic activity in mouse cancer pain model. Acupunct Electrother Res 34:27–40PubMed Lee HJ, Lee JH, Lee EO, Lee HJ, Kim KH, Lee KS, Lee CH, Nam DW, Kim SH, Lee HJ, Ahn KS (2009) Substance P and beta endorphin mediate electroacupuncture induced analgesic activity in mouse cancer pain model. Acupunct Electrother Res 34:27–40PubMed
30.
go back to reference Thornton AA, Madlensky L, Flatt SW, Kaplan RM, Pierce JP (2005) The impact of a second breast cancer diagnosis on health related quality of life. Breast Cancer Res Treat 92:25–33PubMedCrossRef Thornton AA, Madlensky L, Flatt SW, Kaplan RM, Pierce JP (2005) The impact of a second breast cancer diagnosis on health related quality of life. Breast Cancer Res Treat 92:25–33PubMedCrossRef
31.
go back to reference Pariente J, White P, Frackowiak RS, Lewith G (2005) Expectancy and belief modulate the neuronal substrates of pain treated by acupuncture. Neuroimage 25:1161–1167PubMedCrossRef Pariente J, White P, Frackowiak RS, Lewith G (2005) Expectancy and belief modulate the neuronal substrates of pain treated by acupuncture. Neuroimage 25:1161–1167PubMedCrossRef
32.
go back to reference Qin W, Tian J, Bai L, Pan X, Yang L, Chen P, Dai J, Ai L, Zhao B, Gong Q, Wang W, von Deneen K, Liu Y (2008) FMRI connectivity analysis of acupuncture effects on an amygdala-associated brain network. Mol Pain 4:55PubMedCrossRef Qin W, Tian J, Bai L, Pan X, Yang L, Chen P, Dai J, Ai L, Zhao B, Gong Q, Wang W, von Deneen K, Liu Y (2008) FMRI connectivity analysis of acupuncture effects on an amygdala-associated brain network. Mol Pain 4:55PubMedCrossRef
33.
go back to reference Alfhaily F, Ewies AA (2007) Acupuncture in managing menopausal symptoms: hope or mirage? Climacteric 10:371–380PubMedCrossRef Alfhaily F, Ewies AA (2007) Acupuncture in managing menopausal symptoms: hope or mirage? Climacteric 10:371–380PubMedCrossRef
34.
go back to reference Hegadoren KM, O'Donnell T, Lanius R, Coupland NJ, Lacaze-Masmonteil N (2009) The role of beta-endorphin in the pathophysiology of major depression. Neuropeptides 43:341–353PubMedCrossRef Hegadoren KM, O'Donnell T, Lanius R, Coupland NJ, Lacaze-Masmonteil N (2009) The role of beta-endorphin in the pathophysiology of major depression. Neuropeptides 43:341–353PubMedCrossRef
35.
go back to reference Pluchino N, Merlini S, Cubeddu A, Giannini A, Bucci F, Casarosa E, Cela V, Angioni S, Luisi M, Genazzani AR (2009) Brain-region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats. Menopause 16:1037–1043PubMedCrossRef Pluchino N, Merlini S, Cubeddu A, Giannini A, Bucci F, Casarosa E, Cela V, Angioni S, Luisi M, Genazzani AR (2009) Brain-region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats. Menopause 16:1037–1043PubMedCrossRef
36.
go back to reference Akhan SE, Gurel T, Has R, Iyibozkurt AC, Turfanda A (2002) Effects of long-term oral hormone replacement therapy on plasma nitric oxide and beta-endorphin levels in postmenopausal women. Gynecol Obstet Investig 54:196–200CrossRef Akhan SE, Gurel T, Has R, Iyibozkurt AC, Turfanda A (2002) Effects of long-term oral hormone replacement therapy on plasma nitric oxide and beta-endorphin levels in postmenopausal women. Gynecol Obstet Investig 54:196–200CrossRef
37.
go back to reference ter Riet G, de Craen AJ, de Boer A, Kessels AG (1998) Is placebo analgesia mediated by endogenous opioids? A systematic review. Pain 76:273–275PubMedCrossRef ter Riet G, de Craen AJ, de Boer A, Kessels AG (1998) Is placebo analgesia mediated by endogenous opioids? A systematic review. Pain 76:273–275PubMedCrossRef
38.
go back to reference Maclennan AH, Broadbent JL, Lester S, Moore V (2004) Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev CD002978 Maclennan AH, Broadbent JL, Lester S, Moore V (2004) Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev CD002978
39.
go back to reference Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, Lavasseur BI, Rao RM, Fitch TR, Rowland KM, Novotny PJ, Flynn PJ, Richelson E, Fauq AH (2006) Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 24:2836–2841PubMedCrossRef Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, Lavasseur BI, Rao RM, Fitch TR, Rowland KM, Novotny PJ, Flynn PJ, Richelson E, Fauq AH (2006) Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 24:2836–2841PubMedCrossRef
40.
go back to reference Carpenter JS, Storniolo AM, Johns S, Monahan PO, Azzouz F, Elam JL, Johnson CS, Shelton RC (2007) Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist 12:124–135PubMedCrossRef Carpenter JS, Storniolo AM, Johns S, Monahan PO, Azzouz F, Elam JL, Johnson CS, Shelton RC (2007) Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist 12:124–135PubMedCrossRef
41.
go back to reference Col NF, Guthrie JR, Politi M, Dennerstein L (2009) Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause 16:453–457PubMedCrossRef Col NF, Guthrie JR, Politi M, Dennerstein L (2009) Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause 16:453–457PubMedCrossRef
42.
go back to reference White A, Cummings M, Barlas P, Cardini F, Filshie J, Foster NE, Lundeberg T, Stener-Victorin E, Witt C (2008) Defining an adequate dose of acupuncture using a neurophysiological approach–a narrative review of the literature. Acupunct Med 26:111–120PubMedCrossRef White A, Cummings M, Barlas P, Cardini F, Filshie J, Foster NE, Lundeberg T, Stener-Victorin E, Witt C (2008) Defining an adequate dose of acupuncture using a neurophysiological approach–a narrative review of the literature. Acupunct Med 26:111–120PubMedCrossRef
43.
go back to reference Frisk J, Spetz AC, Hjertberg H, Petersson B, Hammar M (2009) Two modes of acupuncture as a treatment for hot flushes in men with prostate cancer-a prospective multicenter study with long-term follow-up. Eur Urol 55:156–163PubMedCrossRef Frisk J, Spetz AC, Hjertberg H, Petersson B, Hammar M (2009) Two modes of acupuncture as a treatment for hot flushes in men with prostate cancer-a prospective multicenter study with long-term follow-up. Eur Urol 55:156–163PubMedCrossRef
44.
go back to reference Borud EK, Alraek T, White A, Fonnebo V, Eggen AE, Hammar M, Astrand LL, Theodorsson E, Grimsgaard S (2009) The Acupuncture on Hot Flushes Among Menopausal Women (ACUFLASH) study, a randomized controlled trial. Menopause 16:484–493PubMedCrossRef Borud EK, Alraek T, White A, Fonnebo V, Eggen AE, Hammar M, Astrand LL, Theodorsson E, Grimsgaard S (2009) The Acupuncture on Hot Flushes Among Menopausal Women (ACUFLASH) study, a randomized controlled trial. Menopause 16:484–493PubMedCrossRef
45.
go back to reference Nedstrand E, Wijma K, Wyon Y, Hammar M (2005) Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study. Climacteric 8:243–250PubMedCrossRef Nedstrand E, Wijma K, Wyon Y, Hammar M (2005) Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study. Climacteric 8:243–250PubMedCrossRef
Metadata
Title
Acupuncture improves health-related quality-of-life (HRQoL) and sleep in women with breast cancer and hot flushes
Authors
Jessica Frisk
Ann-Christine Källström
Najme Wall
Mats Fredrikson
Mats Hammar
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 4/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1134-8

Other articles of this Issue 4/2012

Supportive Care in Cancer 4/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine